Investor Relations Contact Us Careers
Nasdaq: FEMY
Media

Femasys in the
conversation.

Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and women’s health innovation.

Couple reading Femasys content on a tablet
Featured
May 13, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Blog
Read →
May 8, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
Blog
Read →
May 5, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
Blog
Read →
Apr 22, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
Blog
Read →
Apr 22, 2026
Why Women’s Health Innovation Has Lagged – and How Femasys Is Closing the Gap
Blog
Read →
Apr 16, 2026
Femasys Shareholder Update – Q1 2026
Blog
Read →
Press Resources

Everything
journalists need.

Download official logos, executive headshots, product photography, and company fact sheets. For interview requests or additional materials, contact our media relations team directly.

Logo Package
SVG, PNG — light, dark, and color variants
Company Overview
One-page fact sheet • Updated Q2 2026
Product Animations
Animations for FemaSeed, FemBloc, and FemCerv
Media Relations
1-877-336-2562
Investor Relations
ir.femasys.com

For urgent media inquiries or to arrange an executive interview, please include your outlet name, story angle, and publication deadline in your email.

Stay Current

Women’s health news, delivered.

Get the latest Femasys updates — from fertility portfolio commercial progress and FemBloc® U.S. trial milestones to educational events and press releases — directly in your inbox.

You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.